Schatzl G, Reiter W J, Thürridl T, Waldmüller J, Roden M, Söregi S, Madersbacher S
Department of Urology, University of Vienna, Vienna, Austria.
Prostate. 2000 Aug 1;44(3):219-24. doi: 10.1002/1097-0045(20000801)44:3<219::aid-pros6>3.0.co;2-i.
The known importance of the endocrine system, particularly of steroid hormones, for development of the prostate gland and the fact that steroid hormones act as immunmodulators prompted us to compare hypophyseal, adrenal, and gonadal hormones, including cortisol, in patients with benign and malignant prostatic diseases.
Patients with newly diagnosed, untreated prostate cancer (PC) (n = 75) and, as a control population, those with untreated lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) (n = 159) entered this prospective study. In all patients, the following parameters were obtained by serum analysis: prostate-specific antigen (PSA), human luteinizing hormone (hLH), human follicle-stimulating hormone (hFSH), testosterone, estradiol (E2), cortisol, and dehydroepiandrosterone-sulphate (DHEA-S). Serum samples were collected of fasting patients between 7. 30-10.00 AM.
Age was comparable in both groups (PC: 65.6 +/- 7.6 years (mean +/- standard deviation) vs. controls: 64.9 +/- 8. 1 years; P = 0.56). HFSH (PC: 6.6 +/- 3.9 mIU/ml; controls: 8.4 +/- 6.4 mIU/ml; P = 0.04), hLH (PC: 5.3 +/- 4.8mIU/ml; controls: 7.6 +/- 6.2 mIU/ml; P = 0.009), and estradiol (PC: 25.8 +/- 12.7 pg/ml; controls: 32.6 +/- 12.6 pg/ml; P = 0.0003) were significantly lower in PC patients than controls. Cortisol (PC: 16.7 +/- 4.2 microg/dl; controls: 13.5 +/- 4.3 microg/dl; P < 0.0001) was significantly higher in cases. The difference for cortisol and estradiol concentrations between PC patients and controls held true in all life-decades. Serum concentrations for DHEA-S and testosterone were comparable between PC and control patients. In PC patients, none of the endocrine parameters correlated to serum PSA or clinical/pathological stage.
Patients with newly diagnosed, untreated PC yielded significantly higher cortisol and lower estradiol serum concentrations than controls. The known effect of cortisol on the immune status warrants further studies.
内分泌系统,尤其是类固醇激素,对前列腺发育的已知重要性,以及类固醇激素作为免疫调节剂的作用,促使我们比较良性和恶性前列腺疾病患者的垂体、肾上腺和性腺激素,包括皮质醇。
新诊断的未经治疗的前列腺癌(PC)患者(n = 75)以及作为对照人群的因良性前列腺增生(BPH)导致未经治疗的下尿路症状(LUTS)患者(n = 159)进入了这项前瞻性研究。在所有患者中,通过血清分析获得以下参数:前列腺特异性抗原(PSA)、人黄体生成素(hLH)、人卵泡刺激素(hFSH)、睾酮、雌二醇(E2)、皮质醇和硫酸脱氢表雄酮(DHEA-S)。在上午7:30至10:00之间采集空腹患者的血清样本。
两组患者年龄相当(PC组:65.6±7.6岁(平均值±标准差),对照组:64.9±8.1岁;P = 0.56)。PC患者的hFSH(PC组:6.6±3.9 mIU/ml;对照组:8.4±6.4 mIU/ml;P = 0.04)、hLH(PC组:5.3±4.8 mIU/ml;对照组:7.6±6.2 mIU/ml;P = 0.009)和雌二醇(PC组:25.8±12.7 pg/ml;对照组:32.6±12.6 pg/ml;P = 0.0003)显著低于对照组。病例组的皮质醇(PC组:16.7±4.2 μg/dl;对照组:13.5±4.3 μg/dl;P < 0.0001)显著更高。PC患者与对照组之间皮质醇和雌二醇浓度的差异在所有年龄段均成立。PC患者与对照患者之间DHEA-S和睾酮的血清浓度相当。在PC患者中,内分泌参数与血清PSA或临床/病理分期均无相关性。
新诊断的未经治疗的PC患者的皮质醇血清浓度显著高于对照组,雌二醇血清浓度显著低于对照组。皮质醇对免疫状态的已知作用值得进一步研究。